(NASDAQ: FBIO) Fortress Biotech's forecast annual revenue growth rate of 49.31% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 79.5%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.92%.
Fortress Biotech's revenue in 2025 is $59,301,000.On average, 1 Wall Street analysts forecast FBIO's revenue for 2025 to be $3,067,417,487, with the lowest FBIO revenue forecast at $3,067,417,487, and the highest FBIO revenue forecast at $3,067,417,487.
In 2026, FBIO is forecast to generate $4,367,105,098 in revenue, with the lowest revenue forecast at $4,367,105,098 and the highest revenue forecast at $4,367,105,098.